Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of Mortality in Patients With Pneumonia
This cohort study compares 30-day mortality among adult patients hospitalized for pneumonia receiving empirical anti –methicillin-resistant Staphylococcus aureus (MRSA) therapy vs standard empirical antibiotic regimens.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research
More News: Antibiotic Therapy | Infectious Diseases | Internal Medicine | MRSA | Pneumonia | Staphylococcus Aureus | Study | Superbugs